Discontinued — last reported Q3 '23
Citigroup Interest Paid decreased by 5.0% to $20.32B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.7%, from $20.88B to $20.32B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 83.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.82B | $2.35B | $249.00M | $2.78B | $3.50B | $6.27B | $10.06B | $14.36B | $17.45B | $20.07B | $21.12B | $22.12B | $22.06B | $22.97B | $20.88B | $19.39B | $19.90B | $21.38B | $20.32B |
| QoQ Change | — | -16.6% | -89.4% | >999% | +25.9% | +79.1% | +60.3% | +42.8% | +21.5% | +15.0% | +5.2% | +4.7% | -0.2% | +4.1% | -9.1% | -7.1% | +2.6% | +7.5% | -5.0% |
| YoY Change | — | — | — | — | +24.4% | +167.0% | >999% | +416.1% | +398.1% | +219.9% | +109.9% | +54.0% | +26.5% | +14.5% | -1.1% | -12.3% | -9.8% | -6.9% | -2.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.